Tissue ischemia generates potentially immunogenic peptides of autoantigens in the autoimmune disease, scleroderma.
References
Seibold, J.R. Scleroderma. in Textbook of Rheumatology (eds. Kelley, W.N., Harris, E.D., Ruddy, S. & Sledge, C.B.) 1133–1162 (W.B. Saunders Company, Philadelphia, 1997).
Casciola-Rosen, L., Wigley, F., & Rosen, A. Scleroderma autoantigens are uniquely frag-mented by metal-catalyzed oxidation reactions: implications for pathogenesis. J. Exp. Med. 185, 71–79 (1997).
Takeuchi, K., Turley, S.J., Tan, E.M. & Pollard, K.M. Analysis of the autoantibody response to fibrillarin in human disease and murine models of autoimmunity. J. Immunol. 154, 961–971 (1995).
Casciola-Rosen, L.A., Anhalt, G.J. & Rosen, A. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J. Exp. Med. 182, 1625–1634 (1995).
Carvalho, D., Savage, C.O., Black, C.M. & Pearson, J.D. IgG anti-endothelial Cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial Cells in vitro. Induction of adhesion molecule expres-sion and involvement of endothelium-derived cy-tokines. J. Clin. Invest. 97, 111–119 (1996).
Sankar, S. et al. Modulation of transforming growth factor β receptor levels on microvascular endothelial Cells during In vitro angiogenesis. J. Clin. Invest. 97, 1436–1446 (1996).
McAllister, K.A. et al. Endoglin, a TGF-β binding protein of endothelial Cells, is the gene for hered-itary haemorrhagic telangiectasia type 1. Nature Genet. 8, 345–351 (1994).
Bruckdorfer, K.R., Hillary, J.B., Bunce, T., Vancheeswaran, R. & Black, C.M. Increased susceptibility to oxidation of low-density lipopro-teins isolated from patients with systemic sclerosis. Arth. Rheum. 38, 1060–1067 (1995).
Kuwana, M., Medsger, T.A., Jr., & Wright, T.M. T and B Cell collaboration is essential for the autoantibody response to DMA topoisomerase I in systemic sclerosis. J. Immunol. 155, 2703–2714 (1995).
Lehmann, P.B., Sercarz, E.E., Forsthuber, T., Dayan, C.M. & Gammon, G. Determinant spreading and the dynamics of the autoimmune T-Cell repertoire. Immunol. Today 14, 203–208 (1993).
Lanzavecchia, A. How can cryptic epitopes trigger autoimmunity? J. Exp. Med. 181, 1945–1948 (1995).
Wigley, F.M. Raynaud's phenomenon and other features of scleroderma, including pulmonary hypertension. Curr. Opin. Rheumatol. 8, 561–568 (1996).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Peng, S., Fatenejad, S. & Craft, J. Scleroderma: A disease related to damaged proteins?. Nat Med 3, 276–278 (1997). https://doi.org/10.1038/nm0397-276
Issue Date:
DOI: https://doi.org/10.1038/nm0397-276
- Springer Nature America, Inc.
This article is cited by
-
Oxidative stress parameters in localized scleroderma patients
Archives of Dermatological Research (2016)
-
Increasing levels of serum antioxidant status, total antioxidant power, in systemic sclerosis
Clinical Rheumatology (2011)
-
Autoantibody against one of the antioxidant repair enzymes, methionine sulfoxide reductase A, in systemic sclerosis: association with pulmonary fibrosis and vascular damage
Archives of Dermatological Research (2010)